AI
Allostery Investments Portfolio holdings
AUM
$7.85M
This Quarter Return
-7.49%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$50.9M
AUM Growth
–
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
74%
Holding
39
New
30
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$4.77M |
| 2 |
Evolus
EOLS
|
$4.76M |
| 3 |
Apogee Therapeutics
APGE
|
$4.53M |
| 4 |
ABVX
Abivax
ABVX
|
$4.33M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$4.06M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eledon Pharmaceuticals
ELDN
$153M
| $412K | 0.43% |
+100,000
| New | +$412K |
|
|
ORKA
27
Oruka Therapeutics, Inc. Common Stock
ORKA
$583M
| $388K | 0.41% |
+20,000
| New | +$388K |
|
|
ELEV
28
DELISTED
Elevation Oncology
ELEV
| $243K | 0.25% |
+432,206
| New | +$243K |
|
29
ProMIS Neurosciences
PMN
$27.8M
| $185K | 0.19% |
+195,111
| New | +$185K |
|
30
Lexeo Therapeutics
LXEO
$259M
| $33.3K | 0.03% |
+5,054
| New | +$33.3K |
|
31
AnaptysBio
ANAB
$577M
| – | – |
0
| – | – |
|
32
Apellis Pharmaceuticals
APLS
$3.56B
| – | – |
0
| – | – |
|
33
Novavax
NVAX
$1.23B
| – | – |
0
| – | – |
|
34
Olema Pharmaceuticals
OLMA
$444M
| – | – |
0
| – | – |
|
35
iShares 20+ Year Treasury Bond ETF
TLT
$47.3B
| – | – |
0
| – | – |
|
36
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
0
| – | – |
|
37
Invesco QQQ Trust
QQQ
$361B
| – | – |
0
| – | – |
|
38
TG Therapeutics
TGTX
$4.72B
| – | – |
0
| – | – |
|
39
Viridian Therapeutics
VRDN
$1.56B
| – | – |
0
| – | – |
|